Health tech startup SweetSpot announced the integration of an implantable continuous glucose monitoring (CGM) system into its platform. They call it Eversense 365. The company, which specializes in integrating data from diabetes devices like CGMs and insulin pumps, has partnered with the largest private endocrinology practice in the U.S., the Diabetes & Glandular Disease Clinic. […]

Only subscribers get to read this.

Hit SUBSCRIBE for freemium or paid content access.